门静脉血栓形成的当前认识:病因、临床表现与管理
本文聚焦急性和慢性门静脉血栓形成(PVT)的病因、危险因素、临床表现与分类体系,并综述当前诊断与治疗选择。超声、CT 和 MRI 可用于确诊;抗凝治疗是急性与慢性 PVT 的治疗基石,对肝硬化患者启动抗凝需谨慎;对肠缺血、广泛血栓、抗凝禁忌或反应不佳者,微创腔内技术和血管内门体分流术显示有效。
要点
- 超声、CT 和 MRI 均可用于确诊门静脉血栓形成。
- 急性 PVT 可表现为腹痛至肠缺血/梗死甚至死亡,慢性 PVT 可临床沉默。
- 抗凝治疗是急性和慢性 PVT 的治疗基石,肝硬化患者启动时需谨慎。
核心结论
- 熟悉 PVT 的病因、临床表现和分类有助于早期发现并整合有效治疗选择,这类复杂患者的管理应由多学科团队承担。
研究设计与样本
- 综述,围绕急性和慢性 PVT 的病因、危险因素、临床表现、分类体系及当前诊断与治疗选择进行阐述;原文未报告检索范围与纳入文献数量。
诊断标准与关键数值
- 超声、CT 和 MRI 可用于确认 PVT 诊断。
临床应用与阅片要点
- 抗凝治疗是急性与慢性 PVT 治疗的基石,在两种情况下均显示出疗效。
- 肝硬化患者因存在基础凝血功能障碍,启动抗凝治疗时需适当谨慎,当前关注新型口服抗凝药(NOACs)和低分子肝素(LMWH)。
- 对存在肠缺血、广泛血栓、抗凝禁忌或抗凝反应不佳,或因合并症无法抗凝的患者,微创腔内技术提供替代治疗选择。
- 微创导管为基础的治疗和血管内门体分流术在抗凝抵抗患者及广泛或复杂病变患者中显示出疗效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this article is to focus on etiology, risk factors, clinical presentation and classification systems of acute and chronic PVT as well as focusing on current diagnostic and therapeutic options for the management of acute and chronic PVT.
RESULTS: PVT represents a serious clinical concern in cirrhotic patients and in those with specific local or systemic risk factors. The rate and extent of thrombus formation can significantly impact patient presentation and the resulting clinical outcomes. The presentation of acute PVT can range from abdominal pain to intestinal ischemia/infarction and even death, while chronic PVT can remain clinically silent. A number of imaging modalities including US, CT and MRI can be used to confirm the diagnosis. In addition to addressing underlying risk factors, AC therapy forms a cornerstone of treatment and has demonstrated efficacy in both acute and chronic settings. Proper caution should be used when initiating AC therapy in cirrhotic patients given their underlying coagulopathic status with attention now being paid to NOACs and LMWH. For patients with bowel ischemia, extensive thrombosis, contraindications or poor response to AC, or for those with co-morbidities that preclude AC, minimally invasive endovascular techniques offer alternative treatment options.
CONCLUSION: Familiarity with the etiology, clinical presentation and classification of PVT optimize early detection and incorporate effective therapeutic options, the management of these complex patients should be undertaken by a multidisciplinary team. Minimally invasive catheter-based therapies and endovascular portosystemic shunt creation demonstrated efficacy in the treatment of AC-resistant patients and for patients with extensive or complicated disease.
引用
- Alzubaidi S, Patel I, Saini A, et al. Current concepts in portal vein thrombosis: etiology, clinical presentation and management. Abdom Radiol (NY). 2019. PMID: 31407054. doi:10.1007/s00261-019-02174-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。